NCT01523366View on ClinicalTrials.gov

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Stable Coronary Artery Disease
Interventions
DRUG

Ticagrelor

Min - 90mg/Max - 180mg tablets (loading dose)

DRUG

Clopidogrel

75mg (once daily)/Max - 600mg tablets (loading dose)

Trial Locations (5)

Unknown

Research Site, Los Angeles

Research Site, Hollywood

Research Site, Jacksonville

Research Site, Miami

Research Site, Linden

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY